Western University

Scholarship@Western
Paediatrics Publications

Paediatrics Department

3-1-2020

Predictors of Bicuspid Aortic Valve-Associated Aortopathy in
Childhood: A Report From the MIBAVA Consortium
Michael Grattan
Andrea Prince
Rawan K Rumman
Conall Morgan
Michele Petrovic

See next page for additional authors

Follow this and additional works at: https://ir.lib.uwo.ca/paedpub
Part of the Pediatrics Commons

Authors
Michael Grattan, Andrea Prince, Rawan K Rumman, Conall Morgan, Michele Petrovic, Amanda Hauck,
Luciana Young, Anders Franco-Cereceda, Bart Loeys, Salah A Mohamed, Harry Dietz, Seema Mital, ChunPo Steve Fan, Cedric Manlhiot, Gregor Andelfinger, and Luc Mertens

Circulation: Cardiovascular Imaging

ORIGINAL ARTICLE

Predictors of Bicuspid Aortic Valve–
Associated Aortopathy in Childhood
A Report From the MIBAVA Consortium
See Editorial by Simpson
BACKGROUND: Bicuspid aortic valve (BAV) is the most prevalent
congenital heart defect affecting 1% to 2% of the population. It is
associated with ascending aorta dilatation. Valve morphology, aortic
stenosis (AS), and aortic insufficiency (AI) have been proposed as potential
risk factors; however, evaluating their role is difficult, as these factors are
inherently related. The aim of this study was to determine whether BAV
morphology and dysfunction are independent determinants for ascending
aorta dilatation in pediatric patients.
Downloaded from http://ahajournals.org by on May 13, 2021

METHODS: A multicenter, retrospective, cross-sectional study of
pediatric BAV patients followed since 2004 was performed. Imaging
data were assessed for BAV morphology, severity of AS and AI, history of
coarctation, and aortic dimensions. Associations were determined using
multivariable regression analysis. A subset of patients undergoing aortic
interventions (balloon dilation or Ross) were assessed longitudinally.
RESULTS: Data were obtained from 2122 patients (68% male; median
age 10.2 years). Fifty percent of patients had ascending aorta dilatation.
Right and noncoronary cusp fusion, increasing AS and AI, and older age
were independently associated with ascending aorta dilatation. A history
of coarctation was associated with less ascending aorta dilatation. In
patients with neither AS nor AI, 37% had ascending aorta dilatation
(4% severe). No complications related to aortic dilatation occurred in this
cohort. Aortic Z scores were determined, and a Z-score calculator was
created for this population.
CONCLUSIONS: In this large pediatric cohort of patients with BAV,
valve morphology, AS, and AI are independently associated with
ascending aorta dilatation, suggesting that hemodynamic factors
influence aortopathy. However, even in BAVs with no AS or AI, there is
significant ascending aorta dilatation independent of valve morphology.
Interventions that led to changes in degree of AI and AS did not seem
to influence change in aortic dimensions. The current BAV cohort can
be used as a reference group for expected changes in aortic dimensions
during childhood.
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CLINICAL PERSPECTIVE
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Bicuspid aortic valve is known to be associated
with aortic valve dysfunction and ascending
aorta dilatation. Although patients with bicuspid
aortic valve are known to have an increased risk
for aortic dissection, the precise mechanism and
risk factors for this complication are not entirely
clear. Thus, the implications of aortic dilatation,
especially in younger patients with bicuspid aortic valve are not known. This article describes
an association between aortic valve dysfunction
(both stenosis and insufficiency) with ascending
aorta dilatation. Although no causal relationships
could be confirmed, this association will provide
important information to young patients that may
be at higher risk of progressive aortic dilatation
depending on their valve function. The Z scores
that were generated and Z-score calculator that
was created will help practitioners determine the
relative severity of aortic dilatation in their specific
patients. Given the lack of aortic complications in
this cohort, no strict cutoffs for surgical intervention can be recommended; however, providing a
benchmark to compare patients against will remain
helpful given the known association between aortic dilatation severity and dissection. Moreover,
dedicated Z scores for patients with bicuspid aortic
valve are more likely to pick up extreme phenotypes and outliers compared with existing Z scores
for the general population.

B

icuspid aortic valve (BAV) is the most common
congenital heart defect with a prevalence of
≈1.4%.1,2 It is commonly associated with aortic
valve dysfunction and coarctation of the aorta (CoA)
and has been linked to ascending aorta dilatation.3 Less
commonly, BAV has been linked to dilatation of the
more proximal aortic sinuses. Patients with BAV are at
increased risk of complications due to ascending aorta
dilatation including aortic dissection.4
The cause of ascending aorta dilatation in pediatric
patients with BAV is not clear and may involve valve
characteristics (morphology and dysfunction),5 inherent
abnormalities in the arterial vascular structure,6 abnormal flow dynamics,7 and genetic variations.8 Evaluating
the role of valve characteristics as potential risk factors for ascending aorta dilatation has been difficult,
as BAV morphology and function are inherently related.5,9,10 While some of these factors have been studied in adults with BAV, less information is available in
the pediatric population.11 Ascending aorta dilatation
progresses with age and younger patients with significant dilatation can thus be considered as a more severe

presentation of the same disease. Predisposing factors
contributing to ascending aorta dilatation may also be
different in this younger group.
In adults, both genetic and hemodynamic factors
have been described to contribute to BAV aortopathy,
with different factors contributing to different patterns
of aortic dilatation.2 In pediatric patients, the hemodynamic factors mainly relate to valve morphology and
valve dysfunction, as additional comorbidities such as
hypertension are less relevant. The primary objective
of the current study was to determine whether BAV
morphology, valve function, and a history of CoA are
independently related to ascending aorta dilatation
in a large cohort of pediatric patients. Our secondary
objectives were to determine whether these factors
are independently related to aortic sinus dilatation, to
determine the relationships between valve morphology,
valve function and the presence of CoA, and to determine the influence of aortic valve interventions (balloon dilation and Ross procedure) on the progression of
aortic dilatation over time. We also sought to generate
aortic nomograms for patients with BAV that can be
used as a reference for patient follow-up. We hypothesized that aortic valve morphology (specifically right
and noncoronary cusp [R-N] fusion) and valve dysfunction (both aortic stenosis [AS] and insufficiency) would
be associated with ascending aorta dilatation and that
a history of CoA would be associated with decreased
ascending aorta dilatation.

METHODS
Study Design
The MIBAVA (Mechanistic Interrogation of BAV-associated
Aortopathy) Leducq consortium is an international research
collaborative with the goal of determining the cause of
ascending aorta dilatation in patients with BAV. Within this
consortium, we created a registry of patients with BAV followed at the participating centers. This registry was used to
conduct a multicenter, retrospective, cross-sectional study of
all pediatric patients followed with BAV at the Mechanistic
Interrogation of BAV-associated Aortopathy centers, further
expanded to include patients followed at the Ann & Robert
H. Lurie Children’s Hospital, Chicago, IL. Children 0 to 17.9
years of age diagnosed with BAV who underwent at least
one echocardiogram between July 1, 2004, and January 31,
2016, were included. Exclusion criteria for registry inclusion were (1) BAV associated with interrupted aortic arch or
complex congenital heart disease requiring single ventricle
palliation and (2) patients with BAV who underwent aortic valve replacement or aortic root/ascending aorta repair
or replacement before the first available echocardiogram.
Exclusion criteria for detailed analysis and Z-score creation
also included patients with known genetic syndromes, those
with associated congenital heart disease requiring surgery
(with the exception of coarctation), and those with significant congenital heart disease affecting the left heart (mitral
valve disease, sub-AS). A subset of patients who underwent
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aortic valve intervention (balloon dilation or Ross procedure)
at a single center (Hospital for Sick Children) were analyzed
longitudinally for changes in aortic dimensions over time.
Patients were included in longitudinal analysis if they underwent aortic valve balloon dilation or Ross procedure and had
at least 3 echocardiograms available for analysis post-procedure. Mean duration of follow-up for patients in both groups
was 4.7±2.8 years.
The data that support the findings of this study are available from the corresponding author upon reasonable request.
This study was approved by the institutional review committees of each participating institution. No informed consent
was required.

Measurements

Downloaded from http://ahajournals.org by on May 13, 2021

Investigators at each center analyzed echocardiograms to
determine BAV morphology, aortic dimensions (annulus,
sinus, sinotubular junction, and ascending aorta), and the
presence and severity of AS, AI, and CoA. Echocardiograms
before any aortic valve intervention were used to determine
valve morphology. Aortic dimensions and Z scores were
determined from the last echocardiogram before any aortic valve or root intervention. A subset of patients (n=119)
was included that underwent surgical aortic valve repair (but
not replacement) or balloon dilation before 2004. In these
patients, the last echocardiogram before any additional intervention was analyzed. In patients undergoing longitudinal
analysis, every echocardiogram post-balloon dilation or Ross
procedure was analyzed. No further analysis was performed
after a patient underwent a subsequent aortic valve replacement or aortic root repair.
Valve morphology was classified according to presumed
leaflet fusion: right and left coronary cusp (R-L) fusion, R-N
fusion, or left and noncoronary cusp fusion (Figure 1A). If the
valve was unicuspid or the morphology was unclear, it was
excluded from further analysis.
Measurements of the maximal (mid-systolic) aortic dimensions were acquired from the parasternal long-axis view at
the level of the valve annulus, aortic sinuses, sinotubular
junction, and ascending aorta at the level of the right pulmonary artery (Figure 1B). Measurements were converted
into Z-scores based on the hospital for sick children Z-scores
(Table I in the Data Supplement). One of the study sites (site
2) used the leading-edge technique, while all other sites used

the inner-edge technique. Due to this discrepancy, 50 patient
echocardiograms from site 2 were randomly chosen to have
their measurements repeated using the inner-edge technique.
Using Bland-Altman analysis, there were no significant differences between measurement techniques (P value 0.48 for
the aortic sinus and 0.58 for the ascending aorta), and there
was minimal bias (Figure I in the Data Supplement), thus, the
entire cohort was included for analysis. Z scores are standard
in pediatric echocardiographic interpretation given the significant differences in patient size. Aortic dilatation was defined
as a Z score ≥2, while significant dilatation was defined as a
Z score ≥4. The specific pattern of dilatation was described
according to involvement of both the aortic sinuses and
ascending aorta (type 1), ascending aorta alone (type 2), or
aortic sinuses alone (type 3).2 Severity of AS was quantified
from the highest reported mean instantaneous pressure gradient obtained using continuous wave Doppler. Gradients were
stratified according to severity based on previously published
guidelines (none <10 mm Hg; mild, 10–25 mm Hg; moderate, 25–40 mm Hg; and severe, >40 mm Hg).12 AI severity was
determined from the echocardiography report, with readers
quantifying AI severity based on previously published guidelines.13 The presence of CoA on echocardiogram was determined from the echocardiography report, based on isthmus
dimension, peak instantaneous gradient across the isthmus
and the abdominal aorta Doppler flow pattern.

Clinical Profile
Patient charts were reviewed to determine the cardiac history
including associated congenital heart disease, prior surgical or
interventional procedures, complications, and the presence of
genetic syndromes known to affect the aorta.

Statistics
Continuous variables were reported as mean and SD except
for age, which was not normally distributed and was
reported as median and interquartile range. Dichotomous
and polytomous variables were summarized using frequencies. Between-group differences in continuous variables were
assessed using 1-way ANOVA with F tests or Wilcoxon ranksum tests. Between-group differences in categorical variables
were assessed using Fisher exact tests. Outcome variables
(aortic sinus, sinotubular junction, and ascending aorta Z
scores) were assessed both as continuous variables and as

Figure 1. Bicuspid aortic valve (BAV) morphology and aortic measurements.
A, BAV fusion patterns. B, Measurement locations of the aortic sinuses and ascending aorta. 1, aortic annulus; 2, aortic sinus; 3, sinotubular junction; and 4,
ascending aorta. A separate high parasternal view was often used to visualize the ascending aorta. L-N indicates left and noncoronary cusp; R-L, right and left
coronary cusp; and R-N, right and noncoronary cusp. *Right pulmonary artery.
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dichotomous variables using +2 and +4 as the threshold values (ie, dilated Z score >2 or dilated Z score >4 versus nondilated Z score <2).
Multivariable linear regression was applied to quantify the
adjusted associations of independent variables, including BAV
morphology, severity of AS and insufficiency, a history of CoA,
and age, with each Z-score outcome variable. Both 95% CIs
and P values were evaluated based on t statistics.
Next, we developed Z-score models using the LMS method
(Lambda, Mu, Sigma)14 for the maximal aortic valve annulus,
sinus of Valsalva, and ascending aorta dimensions in relation to body surface area. For a given distribution, the LMS
method assesses and quantifies the changes in a distribution by
parametrizing the location (Median, mu), coefficient of variation (sigma), and skewness (lambda) using generalized additive
models. The (possibly nonlinear) associations with the independent variable (ie, body surface area) were separately modeled
and quantified for each of the parameters using cubic splines,
which were estimated using a penalized likelihood method.
Given the nonnegative nature of the dimensions, we considered 3 distributions, namely Box-Cox Cole and Green, Box-Cox
power exponential,15 and t-distributions16 and selected the
one with the optimal Akaike information criteria. To extend
the applicability of this method, a web app was developed for
BAV Z-score calculation (https://sickkidscvdmc.shinyapps.io/
MIBAVA_normogram/).
For the longitudinal analysis, we separately analyzed the
post-balloon and post-Ross longitudinal echo data in patients
with moderate-to-severe versus no or mild aortic insufficiency.
We used the independent estimating equation models to
assess and quantify the association of aortic insuffciency with
aortic annulus, aortic sinus, sinotubular junction, and ascending aorta dimensions. We assessed the time trend using
natural cubic spline, but the nonlinear time trends were not
significant for any of the outcome variables. Hence, we presented the results of the models with a linear trend. The standard errors were estimated using robust sandwich estimators.
Significance level of 5% was applied to all analyses.
Data analysis was conducted using SAS v9.4 (SAS Statistical
Software, Cary, NC) and R v3.4.1 (R Foundation for Statistical
Computing, Vienna, Austria).

RESULTS
Data were obtained from 2122 pediatric patients (0–
17.9 years) followed at 5 institutions. Patient demographics and clinical characteristics are shown in Table 1.
One hundred seventy-one patients were excluded due
to the presence of genetic syndromes, and 388 patients
were excluded due to the presence of significant congenital heart disease leaving a total of 1564 patients for
cross-sectional analysis. For the longitudinal analysis,
309 echocardiograms from 53 patients were included
in the balloon dilation group, and 116 echocardiograms
from 21 patients were included in the Ross procedure
group. Balloon dilation was performed at a median age
of 0.6 years (range, 0–16.0 years), and Ross procedure
was performed at a medium age of 10.6 years (range,

0.6–17.2 years). Of note, no complications related to
aortic dilation occurred in this cohort.

Valve Morphology and Function
The most common BAV morphology was R-L fusion
(65.7%) followed by R-N fusion (32.9%). There were
no significant differences in the frequency of different valve morphology between males and females.
One hundred forty-nine patients had indeterminate or
unicuspid valve morphology and were excluded from
further analysis. Overall, 308 (14.4%) patients had at
least moderate AS and 122 (5.6%) had at least moderate AI. R-L fusion was associated with CoA, while R-N
fusion was associated with AS and AI (Table II in the
Data Supplement).

Aortic Sinus and Ascending Aorta
Dilatation
Fifty percent of patients had aortic sinus or ascending aorta dilatation, or both with the majority having
isolated ascending aorta dilatation. Nine percent of
patients had significant aortic sinus or ascending aorta
dilatation, or both (Z score ≥4; Table 1). There were no
differences in the number of males and females with
ascending aorta dilatation (48.9% versus 46.7%), but
there were slightly more males with aortic sinus dilatation compared with females (12.4% versus 7.7%,
P=0.001). There were no differences in Z scores when
comparing site 2 to the other study sites.
In univariable analysis, R-L fusion was associated
with a larger aortic sinus, while R-N fusion was associated with a larger ascending aorta (Table III in the Data
Supplement). Increasing AS severity was associated
with a smaller aortic sinus and a larger ascending aorta,
while increasing AI severity was associated with a larger
aortic sinus and ascending aorta (Table IV in the Data
Supplement). A history of CoA was inversely associated
with aortic sinus and ascending aorta dilatation (Table
V in the Data Supplement). Valve morphology (R-N
fusion), severity of AS, severity of AI, and absence of
CoA were positively associated with type 1 or 2 dilatation, while valve morphology (R-L fusion) was positively
associated with type 3 dilatation (Tables III through V in
the Data Supplement).
Among the 496 patients with neither AS nor AI,
the mean ascending aorta Z score was 1.6±1.3, with
36.5% of patients having ascending aorta dilatation
and 3.6% having an ascending aorta Z score ≥4.
There were no differences in the ascending aorta Z
score based on valve morphology within this group
(Figure 2; R-L fusion mean 1.51, R-N fusion mean
1.77, P value 0.17).
The results of the multivariable regression analysis
for aortic sinus dimension are shown in Table 2 and
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Table 1. Baseline Clinical Characteristics of the Study Population Were
Summarized
N

Mean (SD)

Age at echo, y (median, IQR)

2122

10.2 (3.9–15.2)

Sex

2122

 Male

1445 (68.1%)

 Female

677 (31.9%)

Medical history
 Known cardiac genetic disorder

2122

171 (8.1%)

  Turner

48

  Marfan

7

  Loeys Dietz/Ehlers Danlos

2

  Other
 Aortic valve fusion type

114
1974*

  R-L

1294 (65.6%)

  R-N

652 (33.0%)

  L-N

28 (1.4%)

 History of AS

2113

  Any AS

743 (35.2%)

  Mild

375 (17.7%)

  Moderate

141 (6.7%)

  Severe

222 (10.5%)

 History of AI

2113

Downloaded from http://ahajournals.org by on May 13, 2021

  Any AI

1129 (53.4%)

  Mild

965 (45.7%)

  Moderate

112 (5.3%)

  Severe

51 (2.4%)

Aortic dilatation (Z score >2.0)
 Any dilatation

2122

1058 (49.9%)

 Aortic sinus

2107

229 (10.9%)

 Sinotubular junction

1278

125 (9.8%)

 Ascending aorta

2081

998 (48%)

 Any dilatation

2122

194 (9.1%)

 Aortic sinus

2107

18 (0.9%)

 Sinotubular junction

1278

9 (0.7%)

 Ascending aorta

2081

184 (8.8%)

Aortic dilatation type

2074

Severe aortic dilatation (Z score >4.0)

 Type 1

172 (8.1%)

 Type 2

822 (38.9%)

 Type 3

53 (2.5%)

Associated cardiac disease

2122

 Any cardiac disease

757 (35.7%)

 Coarctation of aorta

544 (25.6%)

 Sub-aortic stenosis

58 (2.7%)

 Atrial septal defect

207 (9.8%)

 Ventricular septal defect

239 (11.2%)

 Mitral valve disease

142 (6.7%)

 Other

85 (4.0%)

AI indicates aortic insufficiency; AS, aortic stenosis; IQR, interquartile range;
L-N, left and noncoronary cusp fusion; R-L, right and left coronary cusp fusion;
R-N, right and noncoronary cusp fusion; Type 1, aortic sinus and ascending aorta
dilatation; Type 2, isolated ascending aorta dilatation; and Type 3 isolated aortic
sinus dilatation.
*One hundred forty-eight patients had unknown, indeterminate, or possibly
unicuspid valve morphology.

Figure 2. Ascending aorta Z score in patients with no aortic stenosis
(AS) or aortic insufficiency (AI).
R-L indicates right and left coronary cusp fusion; and R-N, right and noncoronary cusp fusion.

Figure II in the Data Supplement. Similar to univariable
analysis, valve morphology (R-L fusion) and severity of
AI were independently associated with aortic sinus dilatation. Severity of AS and a history of CoA were each
inversely associated with aortic sinus dimension.
The results of the multivariable regression analysis
for ascending aorta dimension are shown in Table 2
and Figure III in the Data Supplement. Similar to univariable analysis, valve morphology (R-N fusion), AI,
and AS were independently associated with ascending
aorta dilatation. A history of CoA was inversely associated with ascending aorta dimension. The severity of
ascending aorta dilatation increased with age.
The dimension of the sinotubular junction correlated
with the dimension of the aortic sinus, while there was
less correlation between the dimension of the sinotubular junction and ascending aorta (Figure IV in the Data
Supplement). The relationship between BAV morphology
and valve function with sinotubular junction dimension
was similar to that of the aortic sinus (data not shown).
The results of the longitudinal analysis following
balloon dilation are shown in Table 3. Independent of
AI severity, there was no significant progression in the
aortic valve annulus, sinus of Valsalva, sinotubular junction, or ascending aorta Z scores over time. Patients
with moderate-to-severe AI were more likely to have
a larger aortic annulus, aortic sinus, and sinotubular
junction. The results of the longitudinal analysis following Ross procedure are shown in Figure 3. In the
first 5 years following the Ross procedure, there was a
mild increase in aortic annulus and sinotubular junction
Z scores (P=0.008 and P<0.001, respectively). The aortic sinus and ascending aorta Z scores remained stable
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Table 2. Multivariable Linear Regression Analysis for Aortic Sinus and
Ascending Aorta Dilatation
Aortic Sinus*
Coef (95% CI)

P Value

Ascending
Aorta* Coef
(95% CI)

P Value

BAV fusion type (ref: R-L)
 R-N

−0.446
(−0.589 to −0.303)

<0.001

0.174
(0.019 to 0.329)

0.028

 L-N

−0.090
(−0.671 to 0.490)

0.76

0.123
(−0.488 to 0.733)

0.69

AS severity (ref: no AS)
 Mild

−0.547
(−0.780 to −0.314)

<0.001

0.280
(0.027 to 0.532)

0.030

 Moderate

−0.493
(−0.802 to −0.184)

0.002

0.758
(0.422 to 1.094)

<0.001

 Severe

−0.702
(−0.957 to −0.447)

<0.001

0.862
(0.585 to 1.138)

<0.001

AI severity (ref: no AI)
 Mild

0.260
(0.091 to 0.430)

0.003

0.121
(−0.062 to 0.304)

0.194

 Moderate

1.080
(0.680 to 1.479)

<0.001

0.837
(0.406 to 1.268)

<0.001

 Severe

1.921
(1.480 to 2.363)

<0.001

0.934
(0.449 to 1.418)

<0.001
<0.001

Coarctation
Age, y

−0.262
(−0.429 to −0.095)

0.002

−0.751
(−0.932 to −0.569)

0.032
(0.020 to 0.043)

<0.001

0.018
(0.006 to 0.031)

0.004
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AI indicates aortic insufficiency; AS, aortic stenosis; BAV, bicuspid aortic
valve; L-N, left and noncoronary cusp fusion; R-L, right and left coronary cusp
fusion; and R-N, right and noncoronary cusp fusion.
*Analyses are based on Z scores.

(Figure 3A through 3D). Patients post-balloon dilation
and post-Ross procedure had similar rates of change in
absolute aortic dimensions and aortic Z scores.
Nomograms for the aortic valve annulus, sinus of
Valsalva, and ascending aorta dimensions versus body
surface area are shown in Figure 4. The parameter functions were estimated nonparametrically, thus there is
no simple equation to calculate aortic Z scores. We have
developed a web application which will allow the user
to calculate the Z score based on the patient’s height,
weight, and aortic dimension (https://sickkidscvdmc.
shinyapps.io/MIBAVA_normogram/).

DISCUSSION
In this study, we examined the relationship between
BAV morphology, valve function, and CoA with ascending aorta and aortic sinus dimensions in a large cohort
of pediatric patients. We found a high incidence of
ascending aorta dilatation with about 50% of all
patients having ascending aorta Z scores ≥2 and 9%
having ascending aorta Z scores ≥4. AI and AS severity
are independently associated with significant ascending aorta dilatation. AI severity is independently associated with aortic sinus dilatation, while AS severity is

independently associated with a smaller aortic sinus.
R-N fusion is associated with increased valve dysfunction (AI and AS) but also independently associated with
ascending aorta dilatation. R-L fusion is associated with
CoA and aortic sinus dilatation, while CoA is independently associated with less dilatation of the aortic sinus
and ascending aorta. Patients with significant AI postballoon dilation had more aortic dilatation at baseline;
however, there was little progression over time and
the rate of dilatation was similar to patients without
significant AI post-balloon dilation. Patients post-Ross
procedure had an initial period of progressive dilatation
followed by stabilization of aortic Z scores.
There are 2 main hypotheses on the pathophysiology of BAV aortopathy. The first is that hemodynamic
and rheological factors are responsible for progressive
aortic dilatation. The concept of post-stenotic dilatation
is based on the presence of elevated mechanical wall
stress caused by an upstream flow disturbance. Several
MRI flow studies have suggested that flow disturbances
related to valve dysfunction but also valve morphology
alone cause abnormal localized aortic wall stress resulting in eccentric aortic wall remodeling.17–20 The second
hypothesis suggests a genetic cause resulting in intrinsic aortic wall abnormalities, although identifying specific genes has proven challenging.21,22 Obviously both
hypotheses are not mutually exclusive as there may be
interactions between genetic and hemodynamic factors. Moreover, patients with BAV may prove to be
diverse with a subgroup of patients in whom genetic
factors may be more important. From this perspective,
it is interesting to study bicuspid aortopathy in a pediatric age group as it may help to better understand the
different factors contributing to aortic dilatation.
A first interesting observation from our study was
the independent association between valve morphology (R-N fusion) and ascending aorta dilatation. R-N
fusion is known to be associated with valve dysfunction,
with increased rates of AI and AS,23 a finding confirmed
in our pediatric cohort. Previous pediatric studies have
failed to show any independent association between
valve morphology and ascending aortic dilatation, with
associations observed on univariable analysis likely secondary to the effect of valve morphology on valve dysfunction.5,10 However, the smaller size of these studies
may have limited their ability to detect subtle associations. Recent 4-dimensional MRI flow data suggest that
even in the absence of AS, R-N fusion results in significant flow disturbance in the ascending aorta.7 The
independent association that we observed between
R-N fusion and ascending aorta dilatation may be related to low-velocity flow disturbances. This requires further study in pediatric patients where comorbidities are
less important.
Our data support that valve dysfunction is an important determinant of aortopathy in the pediatric popula-
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Table 3.

Independent Estimating Equation Models for Aortic Dimensions Following Balloon Dilation

Variable

Aortic Valve
Annulus Z Score,
Coef (95% CI)

P Value

Aortic Sinus Z
Score, Coef
(95% CI)

P Value

Sinotubular
Junction Z Score,
Coef (95% CI)

P Value

Ascending Aorta Z
Score, Coef
(95% CI)

P Value

Moderate or
severe AI

2.172
(1.000 to 3.344)

<0.001

1.099
(0.167 to 2.030)

0.021

1.552
(0.398 to 2.707)

0.008

0.603
(−0.560 to 1.765)

0.31

Linear yearly
progression

−0.033
(−0.096 to 0.030)

0.31

0.005
(−0.039 to 0.048)

0.82

0.051
(−0.068 to 0.171)

0.40

−0.006
(−0.127 to 0.115)

0.93

Interaction
between AI

−0.050
(−0.186 to 0.085)

0.47

0.004
(−0.086 to 0.094)

0.93

−0.042
(−0.179 to 0.095)

0.55

0.030
(−0.135 to 0.195)

0.72

AI indicates aortic insufficiency.

tion. Previous pediatric studies have consistently shown
a relationship between AI severity and ascending aorta
dilatation.5,9,10 However, there are conflicting results
regarding the impact of AS, with most groups failing to
show an independent relationship using multivariable

analysis.5,10 Our data confirm the relationship between
AI and ascending aorta dilatation. We also found an
independent relationship between AS and ascending
aorta dilatation. AI and AS are often present together,
making their individual assessment difficult. Our large
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Figure 3. The progression of aortic Z scores over time in patients post-Ross procedure.
A, Aortic valve annulus Z score; B, sinus of Valsalva Z score; C, sinotubular (ST) junction Z score; and D, ascending aorta Z score. Thick line indicates independent
equation estimate; shaded region, 95% CI; and thin dotted lines, individual patient-specific data.
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Figure 4. Nomograms showing the relationship between body surface area and aortic dimensions.
A, aortic valve annulus dimension; B, sinus of Valsalva dimension; and C, ascending aorta dimension, along with proposed Z-score distribution.
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sample size may have allowed us to more accurately
identify the independent associations of AS and AI with
ascending aorta dimension.
Despite the association between valve dysfunction
and aortopathy, we also demonstrated that children
with normally functioning BAVs had increased mean
ascending aorta Z scores, unrelated to valve morphology. Moreover, in patients post-aortic balloon dilation,
there were no significant differences in the subsequent
rate of aortic enlargement based on the presence of
significant AI. These observations suggest that there is
an underlying abnormality increasing the likelihood of
ascending aorta dilatation that is further exacerbated by
valve morphology and dysfunction. Studies in patients
with normal BAV function suggest the presence of flow
abnormalities in the ascending aorta in patients with
aortic dilatation. These abnormalities may be related to
inherent vascular dysfunction,6 abnormal flow dynamics7 or an underlying genetic predisposition,8 and are
subject to ongoing investigation.
The presence of CoA was associated with significantly less aortic sinus, sinotubular junction, and ascending
aorta dilatation. The relationship between CoA and
aortic dilatation in patients with BAV has not been well
defined. Fernandes et.al5 found a similar relationship
with ascending aorta dimension but no relationship
to aortic sinus dimension. R-L fusion is known to be
associated with a higher incidence of CoA.23 This fusion
pattern is also independently associated with larger
aortic sinus dimensions, possibly confounding prior
investigations with smaller sample sizes. CoA is known
to be associated with hypoplasia of the aortic arch and
ascending aorta,24 and recent studies suggest that even
after early repair, precoarctation arteries are thicker and
stiffer compared with controls.25 Abnormalities in vascular function have been detected in neonates before
surgery, suggesting the possibility of an underlying primary vasculopathy.26 These differences may restrict vessel growth and aneurysm formation. Patients with BAV

and CoA may represent a different disease population.
The findings in children seem to contrast with 2 recent
adult studies suggesting that CoA is a risk factor for
ascending aortic complications in patients with BAV.27,28
This requires further study but confounding factors
may include residual arch obstruction and chronic
hypertension.
BAV is also associated with aortic sinus dilatation,
although at a much lower rate than ascending aorta
dilatation. R-L fusion and AI severity are independently
associated with aortic sinus dilatation, while AS severity is independently associated with a smaller aortic
sinus dimension.5,9,29 Our results show a similar relationship, although we suspect that the influence of BAV
morphology on aortic sinus dimension may be overestimated. Standard echocardiographic measurements
from the parasternal long-axis view do not visualize
the entire sinus enface,30 and the elliptical aortic sinus
shape specifically observed with R-L fusion may lead to
overestimation of the sinus dimension when standard
measurement techniques are applied.31 Regarding valve
function, it remains unclear whether aortic sinus dilatation is secondary to AI or whether AI is secondary to a
dilated aortic sinus.5,32 Larger longitudinal studies with
cross-sectional (CT or MR) imaging are needed to further examine this relationship.
The majority of patients exhibited type 2 dilatation,
involving dilatation of the ascending aorta alone. In contrast, adults most commonly exhibit type 1 dilatation
involving both the ascending aorta and aortic sinuses.2
Type 1 dilatation has been found to be most common
in older adults and in those with R-L fusion.2 However, we found that both type 1 and type 2 dilatation
were associated with R-N fusion. As discussed above,
the influence of R-L fusion on aortic sinus dimension
needs further clarification. The increased incidence of
type 1 dilatation in adults may be secondary to abnormal aortic flow or a genetic predisposition that makes
the aortic sinuses more susceptible to progressive dila-
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tation over time.33 There may be distinct differences in
the cause of BAV-associated aortopathy in pediatric and
adult patient populations.
The clinical significance of these findings is important regarding prediction of further dilatation and
possible thresholds for valve and ascending aorta interventions. If flow disturbance is the main contributing
factor to progressive aortopathy this may influence
timing of valve interventions but may also necessitate
surgical strategies that aim to normalize flow patterns
in the aorta. The addition of aortic Z scores for patients
with BAV may contribute to this decision-making process. Although no patients in our cohort had an aortic complication, these Z scores will help practitioners
determine the relative significance of aortic dilatation
in this complex population.

lize within 5 years. We propose that pediatric patients
with BAV have an underlying abnormality increasing
their susceptibility to ascending aorta dilatation that
is further exacerbated by valve dysfunction. Ongoing
study is required to determine the precise mechanisms
of ascending aorta dilatation in patients with and without valve dysfunction.

Limitations

Affiliations

Downloaded from http://ahajournals.org by on May 13, 2021

This study has limitations. Patients were identified in
tertiary care centers, leading to possible referral bias for
more severe aortic valve disease, and a higher incidence
of CoA. Although our large sample size allowed us to
investigate progression of disease and we followed a
subset of the population longitudinally, we did not follow all patients longitudinally to determine their specific rates of aortic growth. Aortic sinus measurements
obtained as per published echocardiographic guidelines may underestimate or overestimate dimensions
compared with cross-sectional imaging due to sinus
asymmetry. Two different measurement techniques
for the aortic dimensions were used. However, we did
not observe that measurement technique significantly
altered the measured aortic dimensions in a random
subset of 50 patients. The classification of aortic regurgitation severity is not quantitative may be subjective, especially when multiple institutions are making
measurements. Lastly, this study did not evaluate the
specific mechanisms for ascending aortic dilatation in
patients with and without valve dysfunction.

Conclusions
Patients with BAV have a high incidence of significant
ascending aorta dilatation. More severe AI and AS are
independently associated with ascending aorta dilatation, although even patients with normal valve function have increased ascending aorta Z scores. After
controlling for valve dysfunction, R-N fusion remains
independently associated with ascending aorta dilatation. The presence of CoA in patients with BAV is
inversely associated with aortic sinus and ascending
aorta dimensions. Following aortic valve balloon dilation aortic Z scores remain stable in patients with and
without significant AI. Immediately after Ross procedure, aortic Z scores increase slightly but then stabi-
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